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In addition to their roles in cellular metabolism and apoptosis, mitochondria function as signaling platforms in
the innate immune response. In Nature, West et al. (2015) demonstrate that mitochondrial stress triggers a
type I interferon response and confers viral resistance via release of mtDNA and activation of the cGAS–
STING pathway.Although known as cellular powerhouses,
mitochondria also regulate apoptotic cell
death pathways. Recently, mitochondria
were shown to help elicit cellular inflam-
mation, particularly by inducing antiviral
signaling pathways. The cytosolic sen-
sors RIG-I andMDA5 signal throughmito-
chondrial antiviral-signaling protein, an
adaptor on the outer mitochondrial mem-
brane (Yoneyama et al., 2015). Damaged
mitochondria have been implicated in
the induction of the NLRP3 inflamma-
some through the production of reactive-
oxygen species and/or the release of
mitochondrial DNA (mtDNA) (Zhou et al.,
2011). In a recent issue of Nature, West
and colleagues (West et al., 2015) demon-
strated that disruption of mtDNA stability,
such as that caused by heterozygosity of
the histone-like mitochondrial transcrip-
tion factor TFAM, results in the release
of mtDNA into the cytosol via an unknown
mechanism. Once in the cytoplasm,
mtDNA elicits interferon (INF) production.
Similar to foreign bacterial and viral DNA
in mammalian cells, mtDNA is recognized
by the cytosolic DNA sensor cGAS.
Activation of cGAS promotes signaling
through the adaptor STING and the tran-
scription factor IRF3, resulting in the in-
duction of type I IFNs and IFN-stimulated
genes (Figure 1).
The physiologic relevance of this
pathway was highlighted in the context
of viral infection. In TFAM+/ mouse em-
bryonic fibroblasts, the enhanced basal
levels of IFN-stimulated genes prevented
infection by either DNA or RNA viruses.
Although this scenario could occur under
certain pathophysiological conditions in
which damaged mitochondria pre-existin the host, the authors also demonstrated
that members of the herpes virus family
caused mitochondrial damage in a UL12
viral protein-dependent manner. Expres-
sion of UL12 alone was sufficient to
induce mitochondrial stress and TFAM
depletion, which enhanced the sensing
of herpes virus infection and increased
antiviral gene production. Again, it is
unclear how such stress results in
the release of mtDNA, though the
effects are evident. UL12 mutant herpes
simplex virus 1 was less immunostimula-
tory and replicated more efficiently
in vitro and in vivo. These findings suggest
that a pathogen-induced mitochondrial
response resulting in the release of
mtDNA is an evolutionarily beneficial
mechanism in the host that amplifies anti-
viral signaling in response to pathogen
invasion. However, the aberrant accumu-
lation of damaged mitochondria and the
leakage of mtDNA into the cytosol may
also cause autoinflammatory or autoim-
mune syndromes.
Two recent articles have highlighted the
role of mtDNA sensing by the cGAS-
STING pathway. White et al. (White
et al., 2014) and Rongvaux et al. (Rong-
vaux et al., 2014) concurrently published
that the activation of caspases involved
in the intrinsic pathway of apoptosis (cas-
pase-3, caspase-7, and caspase-9) pre-
vents activation of the IFN response in
cells undergoing apoptosis mediated by
Bax and Bak. These studies proposed a
model in which the formation of Bax/Bak
pores mediates the release of mtDNA,
thereby triggering cGAS-STING signaling,
IRF3 activation, and type I IFN production.
In most cells, this IFN response is miti-Cell Metabolismgated by the concurrent release of cyto-
chrome c, formation of the apoptosome,
and activation of the downstream effec-
tors caspase-3 and caspase-7, resulting
in apoptotic cell death. Similar to that
of West et al., the article by Rongvaux
et al. demonstrated a profound protection
from both DNA and RNA virus infection
after deletion or inhibition of caspase
activation during Bax/Bak activation.
Intriguingly, the presence of mtDNA in
the cytoplasm of caspase-deficient mice
did not alter the maximal INF response
to virus infection; instead, it resulted in a
pre-existing state of antiviral readiness
due to increased basal stimulation of
cGAS-STING-mediated activation of the
IFN pathway. The cGAS DNA-sensing
pathway also triggers autophagy (Liang
et al., 2014), which can eliminate cytosolic
pathogens. Therefore, it is tempting to
speculate that the pathway elucidated
by West and colleagues, Rongvaux and
colleagues, and White and colleagues
represents an evolutionary adaptation of
a host-pathogen response arising from
the incorporation of a bacterial endosym-
biont (i.e., mitochondria precursor) in an
archaeal host (Gray, 2012).
There is, however, a fundamental flaw
in the idea that Bax and Bak release
mtDNA. While activated, Bax and Bak
clearly permeabilize the outer mitochon-
drial membrane, but the inner mitochon-
drial membrane, which lies between the
mtDNA and the cytosolic sensors, is not
disrupted (Tait and Green, 2010). Thus,
this mechanism is unlikely.
Another potential mechanism is the so-
called mitochondrial-permeability transi-
tion (MPT), which is caused by high21, June 2, 2015 ª2015 Elsevier Inc. 793
Figure 1. Innate Immune Recognition of mtDNA
Under normal conditions, West et al. (2015) demonstrated that the presence of the mitochondrial tran-
scription factor TFAM prevents mitochondrial DNA (mtDNA) damage and release of mtDNA into the cyto-
plasm. However, in the absence of TFAM or in the presence of viral proteins like herpes simplex virus 1
(HSV-1) and UL12 M185 (UL12), mitochondrial damage occurs and mtDNA released into the cytosol is
detected by the cGAS-STING pathway, resulting in IRF3-dependent expression of type I interferons
and other interferon-stimulated genes. Similarly, two recent publications (White et al., 2014; Rongvaux
et al., 2014) demonstrated that the initiation of apoptosis appears to result in mtDNA leakage into the
cytosol with subsequent activation of the same cGAS-STING pathway if caspase-3 and caspase-7, or
caspase-9 were inhibited or deleted. However, the exact mechanisms of mtDNA release remain to be
determined.
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Previewsconcentrations of calcium and other sig-
nals at the innermitochondrial membrane.
During apoptosis, permeabilization of the
outer mitochondrial membrane allows
cytosolic proteases (e.g., caspases and
calpains) to access the inner mitochon-
drial membrane, and this can trigger an
MPT (Sun et al., 2007). However, MPT
opens a small inner-membrane channel
(approximately 1.5 kDa in diameter),
which is not predicted to release mtDNA.794 Cell Metabolism 21, June 2, 2015 ª2015Another possible pathway for intact
mtDNA to be released is mitochondria-
derived vesicles, which sort specific pro-
tein and lipid cargo from mitochondria
into small vesicular carriers (Sugiura
et al., 2014). However, there is no evi-
dence of mtDNA incorporation into those
vesicles, nor is it clear how mtDNA would
escape from those vesicles and activate
cGAS. Perhaps additional insight remains
to be gained by investigatingmechanismsElsevier Inc.of DNA transfer in bacteria. Regardless of
the mechanism by which mtDNA is
released from mitochondria and the
nature of the mtDNA, cytosolic mtDNA
can obviously activate the innate immune
response. Although mechanisms are in
place to keep this response in check,
disruption of those processes may
contribute to aberrant immune response
to pathogens and the etiology of autoim-
mune disorders. The therapeutic potential
of activating or inhibiting this pathway re-
mains to be seen.REFERENCES
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